Patent Assignment
Reel/Frame 050181/0981
Assignment of Assignor's Interest
Recorded: 2019-08-27
Pages: 3
Assignor
SHANNON, PATRICK
Executed: 2017-01-24
Assignee
CANCER PREVENTION PHARMACEUTICALS, INC.
1760 E. RIVER ROAD, SUITE 250, TUCSON, ARIZONA, 85718
Covered Property
(1)
Eflornithine and Sulindac, Fixed Dose Combination Formulation
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 27, 2019
From: DUCASSOU, JEAN
To: SANOFI WINTHROP INDUSTRIE
Reel/Frame 050182/0080 →
Assignment of Assignor's Interest
Aug 27, 2019
From: BRAVO GONZALEZ, ROBERTO CARLOS
To: TILLOTTS PHARMA AG
Reel/Frame 050182/0204 →
Assignment of Assignor's Interest
Aug 27, 2019
From: SANOFI WINTHROP INDUSTRIE S.A.
To: CANCER PREVENTION PHARMACEUTICALS, INC.
Reel/Frame 050182/0313 →
Assignment of Assignor's Interest
Aug 27, 2019
From: TILLOTTS PHARMA AG
To: CANCER PREVENTION PHARMACEUTICALS, INC.
Reel/Frame 050182/0534 →
Assignment of Assignor's Interest
Oct 30, 2025
From: PANBELA THERAPEUTICS, INC.; PANBELA RESEARCH, INC.; CANCER PREVENTION PHARMACEUTICALS, INC.
To: CREATIVE PLANNING BUSINESS ALLIANCE LLC
Reel/Frame 072735/0859 →
Assignment of Assignor's Interest
Nov 3, 2025
From: CREATIVE PLANNING BUSINESS ALLIANCE, LLC
To: USWM, LLC
Reel/Frame 072766/0028 →